Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration

Magnetic Resonance in Medicine

Volumn 71, Issue 6, 2014, Pages 2215-2223

  St Pierre, Tim G ^a   El Beshlawy, Amal ^b   Elalfy, Mohsen ^c   Al Jefri, Abdullah ^d   Al Zir, Kusai ^e   Daar, Shahina ^f   Habr, Dany ^g   Kriemler Krahn, Ulrike ^g   Taher, Ali ^h  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CAIRO UNIVERSITY   (Egypt)

^c AIN SHAMS UNIVERSITY   (Egypt)

^d KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^e National Thalassemia Center   (Syrian Arab Republic)

^f SULTAN QABOOS UNIVERSITY   (Oman)

^g NOVARTIS PHARMA AG   (Switzerland)

^h AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

biopsy; deferasirox; ESCALATOR; iron overload; thalassemia

Indexed keywords

BIOPSY; CALIBRATION; CHELATION; CONVOLUTION; ESCALATORS; IRON; PATIENT MONITORING; PATIENT TREATMENT; SCANNING;

CALIBRATION CURVES; DEFERASIROX; IRON CHELATORS; IRON CONCENTRATIONS; IRON OVERLOADS; LIVER FIBROSIS; NONINVASIVE MEASUREMENTS; SCANNER CALIBRATION;

MAGNETIC RESONANCE IMAGING;

DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; IRON; BENZOIC ACID DERIVATIVE; IRON CHELATING AGENT; TRIAZOLE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CALIBRATION; CHELATION THERAPY; CHILD; COMPARATIVE STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG LIVER LEVEL; DRY WEIGHT; FEMALE; HEPATITIS; HUMAN; IRON OVERLOAD; LIVER BIOPSY; LIVER FIBROSIS; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OPEN STUDY; PROSPECTIVE STUDY; REPRODUCIBILITY; SPIN DENSITY PROJECTION ASSISTED MAGNETIC RESONANCE IMAGING; TREATMENT DURATION; VALIDITY; CLINICAL TRIAL; LIVER; METABOLISM; MULTICENTER STUDY; NEEDLE BIOPSY; PRESCHOOL CHILD; PROCEDURES; TREATMENT OUTCOME; VALIDATION STUDY;

ADOLESCENT; ADULT; BENZOATES; BIOPSY, NEEDLE; CALIBRATION; CHELATION THERAPY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAZOLES;

EID: 84900835793     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24854     Document Type: Article

References (33)

1. Hershko C, Link G, Cabantchik I,. Pathophysiology of iron overload. Ann NY Acad Sci 1998; 850: 191-201.
2. Brittenham GM, Farrell DE, Harris JW, Feldman ES, Danish EH, Muir WA, Tripp JH, Bellon EM,. Magnetic-susceptibility measurement of human iron stores. N Engl J Med 1982; 307: 1671-1675.
3. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW,. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994; 331: 567-573.
4. Brittenham GM, Sheth S, Allen CJ, Farrell DE,. Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease. Semin Hematol 2001; 38: 37-56.
5. Angelucci E, Baronciani D, Lucarelli G, Baldassarri M, Galimberti M, Giardini C, Martinelli F, Polchi P, Polizzi V, Ripalti M,. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 1995; 89: 757-761.
6. Emond MJ, Bronner MP, Carlson TH, Lin M, Labbe RF, Kowdley KV,. Quantitative study of the variability of hepatic iron concentrations. Clin Chem 1999; 45: 340-346.
7. Villeneuve J-P, Bilodeau M, Lepage R, Côté J, Lefebvre M,. Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 1996; 25: 172-177.
8. Kreeftenberg HG, Koopman BJ, Huizenga JR, van Vilsteren T, Wolthers, BG, Gips, CH,. Measurement of iron in liver biopsies-a comparison of three analytical methods. Clin Chim Acta 1984; 144: 255-262.
9. Nielsen P, Engelhardt R, Duerken M, Janka GE, Fischer R,. Using SQUID biomagnetic liver susceptometry in the treatment of thalassemia and other iron loading diseases. Transfus Sci 2000; 23: 257-258.
10. Fischer R, Longo F, Nielsen P, Engelhardt R, Hider RC, Piga A,. Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with β-thalassaemia major: application of SQUID biomagnetic liver susceptometry. Br J Haematol 2003; 121: 938-948.
11. Fischer R, Tiemann CD, Engelhardt R, Nielsen P, Durken M, Gabbe EE, Janka GE,. Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. Am J Hematol 1999; 60: 289-299.
12. Nielsen P, Fischer R, Engelhardt R, Tondury P, Gabbe EE, Janka GE,. Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone. Br J Haematol 1995; 91: 827-833.
13. Sirlin CB, Reeder SB,. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am 2010; 18: 359-81, ix.
14. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnier Y,. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357-362.
15. St Pierre TG, Clark PR, Chua-anusorn W,. Single spin-echo proton transverse relaxometry of iron-loaded liver. NMR Biomed 2004; 17: 446-458.
16. St Pierre TG, Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, Pootrakul P, Robins E, Lindeman R,. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005; 105: 855-861.
17. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD,. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005; 106: 1460-1465.
18. Wood JC, Ghugre N,. Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin 2008; 32: 85-96.
19. Bonkovsky HL, Rubin RB, Cable EE, Davidoff A, Rijcken TH, Stark DD,. Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology 1999; 212: 227-234.
20. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22: 2171-2179.
21. Hankins JS, McCarville MB, Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA, Li CS, Wang WC, Ware RE, Hillenbrand CM,. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood 2009; 113: 4853-4855.
22. Garbowski MW, Carpenter J-P, Smith G, Pennell DJ, Porter JB,. Blood 2009; 114:abst 2004.
23. Christoforidis A, Perifanis V, Spanos G, Vlachaki E, Economou M, Tsatra I, Athanassiou-Metaxa M,. MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations. Eur J Haematol 2009; 82: 388-392.
24. Olivieri NF, Brittenham GM,. Iron-chelating therapy and the treatment of thalassemia. Blood 1997; 89: 739-761.
25. Taher A, El-Beshlawy A, Elalfy MS, Al ZK, Daar S, Habr D, Kriemler-Krahn U, Hmissi A, Al Jefri A,. Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study. Eur J Haematol 2009; 82: 458-465.
26. Taher A, Elalfy MS, Al ZK, Daar S, Al JA, Habr D, Kriemler-Krahn U, El-Ali A, Roubert B, El-Beshlawy A,. Importance of optimal dosing ≥30 mg/kg/d during deferasirox treatment: 2.7-year follow-up from the ESCALATOR study in patients with beta-thalassaemia. Eur J Haematol 2011; 87: 355-365.
27. Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C, Galimberti M, Polchi P, Lucarelli G,. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 2000; 343: 327-331.
28. Soriano-Cubells MJ, Aparisi-Querada L,. Rapid determination of copper, iron and zinc in liver biopsies. Atomic Spectrosc 1984; 5: 217-222.
29. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN,. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
30. Bland JM, Altman DG,. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-160.
31. Clark PR, Chua-anusorn W, St Pierre TG,. Proton transverse relaxation rate (R2) images of liver tissue; mapping local tissue iron concentrations with MRI [corrected]. Magn Reson Med 2003; 49: 572-575.
32. Pavitt HL, Aydinok Y, El-Beshlawy A, Bayraktaroglu S, Ibrahim AS, Hamdy MM, Pang W, Sharples C, St Pierre TG,. The effect of reducing repetition time TR on the measurement of liver R2 for the purpose of measuring liver iron concentration. Magn Reson Med 2011; 65: 1346-1351.
33. Wood JC, Aguilar M, Otto-Duessel M, Nick H, Nelson MD, Moats R,. Influence of iron chelation on R1 and R2 calibration curves in gerbil liver and heart. Magn Reson Med 2008; 60: 82-89.